Adiponectin response to supervised aerobic training in type II diabetic patients

1. Berg AH, Combs TP, Du X, Brownlee M, Scherer PE. The adipocyte-secreted protein Acrp30 enhances hepatic insulin action. Nat Med. 2001; 7:947-53.10.1038/90992Open DOISearch in Google Scholar

2. Weyer C, Funahashi T, Tanaka S, Hotta K, Matsuzawa Y, Pratley RE, et al. Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab. 2001; 86:1930-5.10.1210/jcem.86.5.7463Search in Google Scholar

3. Hotta K, Funahashi T, Arita Y, Takahashi M, Matsuda M, Okamoto Y, I, et al. Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arterioscler Thromb Vasc Biol. 2000; 20:1595-9.10.1161/01.ATV.20.6.1595Open DOISearch in Google Scholar

4. Salmenniemi U, Ruotsalainen E, Pihlajamäki J, Vauhkonen I, Kainulainen S, Punnonen K, et al. Multiple abnormalities in glucose and energy metabolism and coordinated changes in levels of adiponectin, cytokines, and adhesion molecules in subjects with metabolic syndrome. Circulation. 2004; 110:3842-8.10.1161/01.CIR.0000150391.38660.9BSearch in Google Scholar

5. Blüher M, Bullen JW Jr, Lee JH, Kralisch S, Fasshauer M, Kloting N, et al. Circulating adiponectin and expression of adiponectin receptors in human skeletal muscle: associations with metabolic parameters and insulin resistance and regulation by physical training. J Clin Endocrinol Metab. 2006; 91: 2310-6.10.1210/jc.2005-2556Open DOISearch in Google Scholar

6. Lindsay RS, Funahashi T, Hanson RL, Matsuzawa Y, Tanaka S, Tataranni PA, et al. Adiponectin and development of type 2 diabetes in the Pima Indian population. Lancet. 2002; 360:57-8.10.1016/S0140-6736(02)09335-2Search in Google Scholar

7. Schulze MB, Shai I, Rimm EB, Li T, Rifai N, Hu FB. Adiponectin and future coronary heart disease events among men with type 2 diabetes. Diabetes. 2005; 54:534-9.10.2337/diabetes.54.2.53415677512Open DOISearch in Google Scholar

8. Wei EK, Giovannucci E, Fuchs CS, WillettWC, Mantzoros CS. Low plasma adiponectin levels and risk of colorectal cancer in men: a prospective study. J Natl Cancer Inst. 2005; 97:1688-94.10.1093/jnci/dji37616288122Search in Google Scholar

9. Luhn P, Dallal CM, Weiss JM, Black A, Huang WY, Lacey JV Jr, et al. Circulating adiponectin and endometrial cancer risk. J Clin Endocrinol Metab. 2004; 89:1160-3.10.1210/jc.2003-03171615001602Search in Google Scholar

10. Waki H, Yamauchi T, Kamon J, Ito Y, Uchida S, Kita S, et al. Impaired multimerization of human adiponectin mutants associated with diabetes: molecular structure and multimer formation of adiponectin. J Biol Chem. 2003; 278:40352-63.10.1074/jbc.M30036520012878598Search in Google Scholar

11. Wang Y, Lam KS, Chan L, Chan KW, Lam JB, Lam MC, et al. Posttranslational modifications on the four conserved lysine residues within the collagenous domain of adiponectin are required for the formation of its high-molecular-weight oligomeric complex. J Biol Chem. 2006; 281:16391-400.10.1074/jbc.M51390720016621799Search in Google Scholar

12. Hara K, Horikoshi M, Yamauchi T, Yago H, Miyazaki O, Ebinuma H, et al. Measurement of the high molecular weight form of adiponectin in plasma is useful for the prediction of insulin resistance and metabolic syndrome. Diabetes Care. 2006; 29:1357-62.10.2337/dc05-180116732021Open DOISearch in Google Scholar

13. Berg AH, Scherer PE. Adipose tissue, inflammation, and cardiovascular disease. Circ Res. 2005; 96:939-49.10.1161/01.RES.0000163635.62927.3415890981Search in Google Scholar

14. Onay-Besikci A, Altarejos JY, Lopaschuk GD. gAdglobular head domain of adiponectin increases fatty acid oxidation in newborn rabbit hearts. J Biol Chem. 2004; 279:44320-6.10.1074/jbc.M40034720015269215Search in Google Scholar

15. Ferguson MA, White LJ, McCoy S, Kim HW, Petty T, Wilsey J. Plasma adiponectin response to acute exercise in healthy subjects. Eur J Appl Physiol. 2004; 91:324-9.10.1007/s00421-003-0985-114586663Open DOISearch in Google Scholar

16. Kraemer RR, Aboudehen KS, Carruth AK, Durand RT, Acevedo EO, Hebert EP, et al. Adiponectin responses to continuous and progressively intense intermittent exercise. Med Sci Sports Exerc. 2003; 35:1320-5.10.1249/01.MSS.0000079072.23998.F312900685Open DOISearch in Google Scholar

17. Punyadeera C, Zorenc AH, Koopman R, McAinch AJ, Smit E, Manders R, et al. The effects of exercise and adipose tissue lipolysis on plasma adiponectin concentration and adiponectin receptor expression in human skeletal muscle. Eur J Endocrinol. 2005; 152: 427-36.10.1530/eje.1.0187215757860Search in Google Scholar

18. Jurimae J, Purge P, Jurimae T. Adiponectin is altered after maximal exercise in highly trained male rowers. Eur J Appl Physiol. 2005; 93:502-5.10.1007/s00421-004-1238-715618990Search in Google Scholar

19. Kriketos AD, Gan SK, Poynten AM, Furler SM, Chisholm DJ, Campbell LV. Exercise increases adiponectin levels and insulin sensitivity in humans. Diabetes Care. 2004; 27:629-30.10.2337/diacare.27.2.62914747265Open DOISearch in Google Scholar

20. Bobbert T, Wegewitz U, Brechtel L, Freudenberg M, Mai K, Möhlig M, et al. Adiponectin oligomers in human serum during acute and chronic exercise: relation to lipid metabolism and insulin sensitivity. Int J Sports Med. 2007; 28:1-8.10.1055/s-2006-92402817133288Open DOISearch in Google Scholar

21. Boudou P, Sobngwi E, Mauvais-Jarvis F, Vexiau P, Gautier JF. Absence of exercise-induced variations in adiponectin levels despite decreased abdominal adiposity and improved insulin sensitivity in type 2 diabetic men. Eur J Endocrinol. 2003; 149:421-4.10.1530/eje.0.149042114585088Search in Google Scholar

22. Yoshida H, Ishikawa T, Suto M, Kurosawa H, Hirowatari Y, Ito K, et al. Effects of supervised aerobic exercise training on serum adiponectin and parameters of lipid and glucose metabolism in subjects with moderate dyslipidemia. J Atheroscler Thromb. 2010; 17:1160-6.10.5551/jat.435820805637Open DOISearch in Google Scholar

23. American Diabetes Association. Standards of medical care in diabetes. Diabetes Care. 2009; 32:S13-61.10.2337/dc09-S013261358919118286Search in Google Scholar

24. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985; 28:412-9.10.1007/BF002808833899825Open DOISearch in Google Scholar

25. Okita K, Iwahashi H, Kozawa J, Okauchi Y, Funahashi T, Imagawa A, et al. Homeostasis model assessment as a clinical index of insulin resistance in type 2 diabetic patients treated with sulfonylureas. Diabetes Care. 1999; 22:818-22.10.2337/diacare.22.5.81810332688Open DOISearch in Google Scholar

26. Katsuki A, Sumida Y, Gabazza EC, Murashima S, Furuta M, Araki-Sasaki R, et al. Homeostasis model assessment is a reliable indicator of insulin resistance during follow-up of patients with type 2 diabetes. Diabetes Care. 2001; 24:362-5.10.2337/diacare.24.2.36211213893Open DOISearch in Google Scholar

27. Ebinuma H, Miyazaki O, Yago H, Hara K, Yamauchi T, Kadowaki T. A novel ELISA system for selective measurement of human adiponectin multimers by using proteases. Clin Chim Acta. 2006; 372:47-53.10.1016/j.cca.2006.03.01416697359Search in Google Scholar

28. Karvonen M, Kentala K, Mustala O. The effects of training heart rate: a longitudinal study. Ann Med Exp Biol Fenn. 1957; 35:307-15.Search in Google Scholar

29. Hu E, Liang P, Spiegelman BM. Adipo Q is a novel adipose-specific gene dysregulated in obesity. J Biol Chem. 1996; 271:10697-703.10.1074/jbc.271.18.106978631877Search in Google Scholar

30. Hotta K, Funahashi T, Arita Y, Takahashi M, Matsuda M, Okamoto Y, et al. Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arter Throm Vasc Biol. 2000; 20:1595-9.10.1161/01.ATV.20.6.1595Open DOISearch in Google Scholar

31. Yang WS, Lee WJ, Funahashi T, Tanaka S, Matsuzawa Y, Chao CL, et al. Weight reduction increases plasma levels of an adipose-derived anti-inflammatory protein, adiponectin. J Clin Endo Metab. 2001; 86: 3815-9.10.1210/jcem.86.8.774111502817Search in Google Scholar

32. Phillips SA, Ciaraldi TP, Kong AP, Bandukwala R, Aroda V, Carter L, et al. Modulation of circulating and adipose tissue adiponectin levels by antidiabetic therapy. Diabetes. 2003; 52:667-74.10.2337/diabetes.52.3.66712606507Search in Google Scholar

33. Goodyear LJ, Kahn BB. Exercise, glucose transport, and insulin sensitivity. Ann Rev Med. 1998; 49: 235-61.10.1146/annurev.med.49.1.2359509261Search in Google Scholar

34. Sajad A, Amir HH, Mohammad R H. Effects of resistance versus endurance training on serum adiponectin and insulin resistance index. Eur J Endocrinol. 2007; 157:625-31.10.1530/EJE-07-022317984242Search in Google Scholar

35. Dela F, Handberg A, Mikines KJ, Vinten J, Galbo H. GLUT4 and insulin receptor binding and kinase activity in trained human muscle. J Physiol. 1993; 469: 615-24.10.1113/jphysiol.1993.sp01983311438908271219Search in Google Scholar

36. Dela F1, Ploug T, Handberg A, Petersen LN, Larsen JJ, Mikines KJ, et al. Physical training increases muscle GLUT4 protein and mRNA in patients with NIDDM. Diabetes. 1994; 43:862-5.10.2337/diab.43.7.8628013748Search in Google Scholar

37. Oberbach A, Tonjes A, Kloting N, Fasshauer M, Kratzsch J, Busse MW, et al. Effect of a 4 week physical training program on plasma concentrations of inflammatory markers in patients with abnormal glucose tolerance. Eur J Endocrinol. 2006; 154:577-85.10.1530/eje.1.0212716556721Search in Google Scholar

38. Klimcakova E, Polak J, Moro C, Hejnova J, Majercik M, Viguerie N, et al. Dynamic strength training improves insulin sensitivity without altering plasma levels and gene expression of adipokines in subcutaneous adipose tissue in obese men. J Clin Endocrinol Metab. 2006; 91:5107-12.10.1210/jc.2006-038216968804Open DOISearch in Google Scholar

39. Waki H, Yamauchi T, Kamon J, Ito Y, Uchida S, Kita S, et al. Impaired multimerization of human adiponectin mutants associated with diabetes: molecular structure and multimer formation of Adiponectin. J Biol Chem. 2003; 278:40352-63.10.1074/jbc.M30036520012878598Search in Google Scholar

40. Kadowaki T, Yamauchi T, Kubota N, Hara K, Ueki K, Tobe K. Adiponectin and adiponectin receptors in insulin resistance, diabetes, and metabolic syndrome. J Clin Invest. 2006; 116:1784-92. 10.1172/JCI29126148317216823476Search in Google Scholar